Pediatrix Medical Group, Inc. financial data

Symbol
MD on NYSE
Industry
Services-Hospitals
Location
1301 Concord Terrace, Sunrise, FL
State of incorporation
FL
Fiscal year end
December 31
Former names
MEDNAX, INC. (to 6/21/2022)
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % +16.5%
Debt-to-equity 174 % +16.2%
Return On Equity -13 % -96.6%
Return On Assets -4.72 % -79.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.8M shares
Common Stock, Shares, Outstanding 85.9M shares +2.2%
Entity Public Float 637M USD -45.8%
Common Stock, Value, Issued 859K USD +2.26%
Weighted Average Number of Shares Outstanding, Basic 83.3M shares +1.37%
Weighted Average Number of Shares Outstanding, Diluted 83.3M shares +1.37%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 238M USD +4.79%
Operating Income (Loss) -68.7M USD -1039%
Nonoperating Income (Expense) -32.6M USD +41.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -101M USD -110%
Income Tax Expense (Benefit) -2.27M USD -119%
Net Income (Loss) Attributable to Parent -99.1M USD -64%
Earnings Per Share, Basic -1.19 USD/shares -63%
Earnings Per Share, Diluted -1.19 USD/shares -63%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 230M USD +214%
Accounts Receivable, after Allowance for Credit Loss, Current 260M USD -4.53%
Other Assets, Current 5.09M USD -58.7%
Assets, Current 640M USD +32.3%
Deferred Income Tax Assets, Net 104M USD +0.98%
Property, Plant and Equipment, Net 39.2M USD -48.2%
Operating Lease, Right-of-Use Asset 34.1M USD -44.7%
Goodwill 1.24B USD -10.2%
Other Assets, Noncurrent 76.6M USD -6.78%
Assets 2.15B USD -3.02%
Accounts Payable, Current 46.4M USD +34.2%
Liabilities, Current 434M USD +11.6%
Long-term Debt and Lease Obligation 597M USD -3.45%
Deferred Income Tax Liabilities, Net 34.2M USD -0.18%
Operating Lease, Liability, Noncurrent 31.9M USD -32.4%
Other Liabilities, Noncurrent 32.9M USD +7.64%
Liabilities 1.39B USD +1.24%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.07M USD +51.6%
Retained Earnings (Accumulated Deficit) -249M USD -66.3%
Stockholders' Equity Attributable to Parent 765M USD -9.91%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 765M USD -9.91%
Liabilities and Equity 2.15B USD -3.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -125M USD -24.1%
Net Cash Provided by (Used in) Financing Activities 76.2M USD -29.8%
Net Cash Provided by (Used in) Investing Activities -16.2M USD -43.1%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85.9M shares +2.2%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -65.3M USD -1664%
Deferred Tax Assets, Valuation Allowance 425M USD -2.42%
Deferred Tax Assets, Gross 669M USD -2.58%
Operating Lease, Liability 44.6M USD -34.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -97.9M USD -66.3%
Lessee, Operating Lease, Liability, to be Paid 49.9M USD -34.8%
Property, Plant and Equipment, Gross 166M USD -24.1%
Operating Lease, Liability, Current 12.7M USD -39.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.2M USD -29.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.7M USD -38.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 686K USD -65.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.24M USD -36.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.69M USD -22.1%
Deferred Tax Assets, Operating Loss Carryforwards 47.9M USD +37.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 2.4M USD -1.92%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.36M USD -28.6%
Depreciation, Depletion and Amortization 32.2M USD -10.9%
Deferred Tax Assets, Net of Valuation Allowance 243M USD -2.85%
Share-based Payment Arrangement, Expense 9.9M USD -19.5%
Interest Expense 41.4M USD +0.67%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%